Sino Biopharmaceutical (HK:1177) has released an update.
Sino Biopharmaceutical Limited has announced that between June 5 and June 13, 2024, its subsidiary Chia Tai Tianqing Pharmaceutical Group Co., Ltd. has purchased approximately 0.08% of the company’s shares, totaling 15,842,000 shares at an average price of HKD2.82 each, for around HKD44.65 million. These shares are part of a Share Incentive Scheme to grant share-based incentives to selected participants, with future grants and purchases to be determined by the board of directors.
For further insights into HK:1177 stock, check out TipRanks’ Stock Analysis page.
